CLINICAL TRIALS AND OBSERVATIONS Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34 cells from leukapheresis products autografted during the first remission
نویسندگان
چکیده
1Department of Hematology, Hôpital Saint Antoine, Paris, France; 2Acute Leukemia Working Party, European Cooperative Group for Blood and Marrow Transplantation, Faculté de Médecine St-Antoine Université Pierre et Marie Curie Paris 6 and Unité Mixte de Recherche (UMR) 893, Paris, France; 3Centre Hospitalier Universitaire Bordeaux Hôpital Haut-Leveque, Pessac, France; 4Unité de transplantation et de thérapie cellulaire, Institut Paoli Calmettes, Inserm UMR 599, Marseille, France; 5Hématologie & Médecine Interne, Hôpital de Brabois, Nancy, France; 6Department of Haematology, University Medical Center Saint Radboud, Nijmegen, The Netherlands; 7Dipartimento di Biotecnologie Cellulari e Ematologia, University La Sapienza, Rome, Italy; 8Department of Hematology, Hôpital Purpan Centre Hospitalier Universitaire, Toulouse, France; 9Clinical Hematology Department, University Hospital of Asturias, Oviedo, Spain; and 10Department of Hematology and Bone Marrow Transplantation, Hôpital Saint Louis, Paris, France
منابع مشابه
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation
A retrospective analysis of granulocyte colony-stimulating factor (G-CSF)–mobilized peripheral blood mononuclear cell (G-PBMC) products harvested from healthy donors indicates significant variability in both the absolute number and relative proportion of CD34, CD3, and CD14 cells obtained. This report examined whether variations in the cellular composition of G-PBMC products correlated with cli...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
To evaluate the incidence and clinical impact of WT1 gene mutations in younger adult patients with cytogenetically normal acute myeloid leukemia (CN-AML), sequencing of the complete coding region was performed in diagnostic samples from 617 patients who were treated on 3 German-Austrian AML Study Group protocols. WT1 mutations were identified in 78 (12.6%) of the 617 patients; mutations cluster...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution’s experience
To describe the clinical and biologic features of pediatric acute megakaryoblastic leukemia (AMKL) and to identify prognostic factors, experience at St Jude Children’s Research Hospital was reviewed. Of 281 patients with acute myeloid leukemia treated over a 14-year period, 41 (14.6%) had a diagnosis of AMKL. Six patients had Down syndrome and AMKL, 6 had secondary AMKL, and 29 had de novo AMKL...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Therapy of Molecular Relapse in Acute Promyelocytic Leukemia
Fourteen patients with PML/RARa-positive acute promyelocytic leukemia (APL) were given salvage therapy at the time of first molecular relapse. All patients had achieved first molecular remission after the AIDA protocol (all-trans retinoic acid [ATRA] 1 idarubicin) and were being prospectively monitored by reverse transcriptase-polymerase chain reaction (RT-PCR). Molecular relapse was defined as...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Allografts from HLA-matched sibling donors were mobilized and collected without granulocyte colony-stimulating factor (G-CSF) using AMD3100, a direct antagonist of CXCR4/stromal-derived factor 1 (SDF-1/CXCL12). Donors (N 25) were treated with AMD3100 at a dose of 240 g/kg by subcutaneous injection, and leukapheresis was then initiated just 4 hours later. Two-thirds of the donors collected an al...
متن کامل